NCT07321899ClinicalTrials.gov
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER
In breve
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Interventistico1186 partecipanti ricercati20 centri1 paese
Categorie
Registrato in 1 registro
- ClinicalTrials.govNCT07321899Apri questa scheda su ClinicalTrials.govSincronizzato settimana scorsa
Uno studio può essere registrato in più registri. Lo mostriamo una volta sola e colleghiamo ogni scheda in nostro possesso.
Le informazioni sulla sperimentazione sono mostrate così come pubblicate dal registro, nella lingua originale.
Ti interessa questo studio?
Accedi oppure crea un account per registrare il tuo interesse e seguire questo studio.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2026-01-07; recorded start 2026-09-11
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 19 other studies in this databaseCounted from the lead sponsor named in the record (Medtronic Cardiovascular)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding7/20
Single-blind
- Control arm15/15
Active-comparator control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 4 sites
- Data monitoring committee7/7
A data monitoring committee is in place
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study: 1,186 participants (target), run at 20 sites.
How this score is built
- Enrolment31/40
1,186 participants (target)
- Site count7/25
4 sites
- Country count0/15
Single country
- Planned duration10/10
Planned over about 179 months
- Sponsor scale4/10
Medtronic Cardiovascular has led 19 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Sintesi
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Patologie
- Severe Tricuspid Regurgitation
Idoneità
| Sesso | Tutti |
|---|---|
| Età | 18 Years – Nessun massimo |
| Volontari sani | No |
Idoneità come riportata nel registro
Idoneità in frasi semplici
I criteri di questa scheda non sono ancora stati suddivisi in affermazioni distinte. Il testo del registro qui sopra è completo ed è la versione autorevole.
Disegno dello studio
| Tipo di studio | Interventistico |
|---|---|
| Fase | Non applicabile |
| Assegnazione | Randomizzata |
| Modello di intervento | PARALLEL |
| Finalità principale | TREATMENT |
| Mascheramento | SINGLE (1) |
| Arruolamento | 1186 partecipanti ricercati |
Sponsor e collaboratori
- Medtronic Cardiovascular Sponsor
Bracci e interventi
- Medtronic Intrepid™ TTVREXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.
- Edwards EVOQUE TTVRACTIVE_COMPARATOR
Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.
- Single Arm RegistryEXPERIMENTAL
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.
Interventi
- Dispositivo Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
- Dispositivo Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Transcatheter Tricuspid Valve Replacement
Esiti misurati
Esito primario
Rate of Major Adverse Events (MAE)
Orizzonte temporale 30-days post-procedure
Esito primario
Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention
Orizzonte temporale 1-year post-procedure
Esito secondario
Tricuspid regurgitation (TR) grade reduction
Total number of patients with at least one grade TR reduction
Orizzonte temporale 6 months post-procedure
Esito secondario
Change in quality of life (QoL) as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) from baseline
KCCQ overall summary score is a patient-reported measure of health status. Scores range from 0 to 100 where higher scores reflect better quality of life
Orizzonte temporale 6 months post-procedure
Esito secondario
All-cause mortality
Orizzonte temporale 12 months post-procedure
Esito secondario
Heart failure hospitalization
Orizzonte temporale 12 months post-procedure
Esito secondario
New onset conduction disturbance (NOCD)
Orizzonte temporale 30 days post-procedure
Esito secondario
Total procedure time
Orizzonte temporale Procedure
Esito secondario
Right ventricle (RV) dysfunction
Orizzonte temporale 12 months post-procedure
Date
| Data di inizio | 11 settembre 2026 (effettiva) |
|---|---|
| Conclusione primaria | 1 settembre 2031 (stimata) |
| Conclusione | 1 aprile 2041 (stimata) |
| Prima pubblicazione | 7 gennaio 2026 (effettiva) |
| Ultimo aggiornamento | 12 novembre 2026 |
| Risultati pubblicati | Non indicato nella scheda del registro |
| Stato verificato l'ultima volta | novembre 2026 |
«Effettiva» significa che l'evento è avvenuto. «Stimata» significa che lo sponsor lo prevede. Le due cose non sono equivalenti.
Centri
20 centri stanno reclutando
United States
| Struttura | Città | Stato o regione | Stato |
|---|---|---|---|
| Emory University Hospital Midtown | Atlanta | Georgia | In reclutamento |
| University of Alabama at Birmingham (UAB) Hospital | Birmingham | Alabama | In reclutamento |
| Buffalo General Medical Center | Buffalo | New York | In reclutamento |
| Northwestern Memorial Hospital | Chicago | Illinois | In reclutamento |
| The Christ Hospital | Cincinnati | Ohio | In reclutamento |
| Cleveland Clinic Foundation | Cleveland | Ohio | In reclutamento |
| Hartford Hospital | Hartford | Connecticut | In reclutamento |
| Cedars Sinai Medical Center | Los Angeles | California | In reclutamento |
| Northwell Health North Shore University Hospital | Manhasset | New York | In reclutamento |
| Abbott Northwestern Hospital | Minneapolis | Minnesota | In reclutamento |
| Morristown Medical Center | Morristown | New Jersey | In reclutamento |
| Yale New Haven Hospital | New Haven | Connecticut | In reclutamento |
| Montefiore Medical Center | New York | New York | In reclutamento |
| NYU Langone Medical Center | New York | New York | In reclutamento |
| The Valley Hospital | Paramus | New Jersey | In reclutamento |
| Abrazo Arizona Heart Hospital | Phoenix | Arizona | In reclutamento |
| Kaiser Permanente San Francisco Medical Center | San Francisco | California | In reclutamento |
| Los Robles Hospital & Medical Center | Thousand Oaks | California | In reclutamento |
| Ascension Via Christi Saint Francis | Wichita | Kansas | In reclutamento |
| Lankenau Institute for Medical Research | Wynnewood | Pennsylvania | In reclutamento |
Documenti dello studio
In questa scheda del registro non sono collegati documenti.
Modifiche nel tempo
- 12 novembre 2026
Centro aggiunto
7 sites added (20 total)
1320
- 25 settembre 2026
Centro aggiunto
9 sites added (13 total)
413
- 28 luglio 2026
Stato modificato
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 28 luglio 2026
Reclutamento aperto
Recruitment opened
NOT_YET_RECRUITINGRECRUITING
- 28 luglio 2026
Centro aggiunto
4 sites added (4 total)
04